Results

Total Results: 2,204 records

Showing results for "drugs".

1801. The Effectiveness of Indoor Allergen Reduction and the Role of Bronchial Thermoplasty in the Management of Asthma | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/asthma-nonpharmacologic-treatment/research-protocol
      April 01, 2021 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

1802. Long COVID Models of Care (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/long-covid-protocol.pdf
      February 18, 2023 - Prevention [CDC], the National Institute for Health and Care Excellence [NICE] UK, the Canadian Agency for Drugs

1803. Long COVID Models of Care | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/long-covid-models-care/protocol
      June 01, 2023 - Prevention [CDC], the National Institute for Health and Care Excellence [NICE] UK, the Canadian Agency for Drugs

1804. Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/outcomes-testing-evaluation/research
      January 01, 2019 - five-item scale 1 month after the normal test, fewer had chest pain, and fewer patients were taking cardiac drugs

1805. Treatment of Osteoarthritis of the Knee: An Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
      June 15, 2016 - Voltaren® Diclofenac transdermal patch (FLECTOR® IBSA Institut Biochimique SA, licensed by Alpharma Pharmaceuticals … FDA Approval for Indicated Use CMS Coverage Brand Names Voltaren® Gel Diclofenac topical (Endo Pharmaceuticals

1806. Evidence Report on the (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
      February 01, 2008 - Boehringer Ingelheim GmbH Investigational drug, not yet FDA approved Desirudin (Iprivask®) Canyon Pharmaceuticals … Lepirudin (Refludan®) Bayer Healthcare Pharmaceuticals Anticoagulation in patients with heparin-associated

1807. Evidence Report on the (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
      February 01, 2008 - Boehringer Ingelheim GmbH Investigational drug, not yet FDA approved Desirudin (Iprivask®) Canyon Pharmaceuticals … Lepirudin (Refludan®) Bayer Healthcare Pharmaceuticals Anticoagulation in patients with heparin-associated

1808. Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
      December 01, 2019 - Boehringer Ingelheim GmbH Investigational drug, not yet FDA approved Desirudin (Iprivask®) Canyon Pharmaceuticals … Lepirudin (Refludan®) Bayer Healthcare Pharmaceuticals Anticoagulation in patients with heparin-associated

1809. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/transparency-omega-3/research-protocol
      January 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

1810. Breast Reconstruction After Mastectomy | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/breast-reconstruction-mastectomy/protocol
      July 01, 2021 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

1811. Glaucoma-Screening Surveillance (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening_surveillance.pdf
      January 01, 2013 - CER #59: Screening for Glaucoma: Comparative Effectiveness Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: - A number of new studies were identified assessing the sensitivity and specificity of the Heidelberg Retina Tomograph 3, optical coherence tomography (OCT), and …

1812. Chronic-Urinary-Retention Research (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
      September 01, 2014 - Most approaches (including surgery, minimally invasive procedures, and drugs) address the underlying … urinary retention Chronic Urinary Retention T reatment • Catheterization • Surgical procedures • Drugs

1813. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
      April 11, 2016 - The"primary"goal"of"this"review"is"to"identify"any"missing"studies," drugs,"interventions,"or"devicesl"and"ensure"the"accuracy"of"our"synthesis"of"the"recently

1814. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
      January 01, 2014 - Public Biomarin Findings Page 18 Sentence 1 Minor typo: . . .drugs may be used to Typo corrected

1815. Behavioral Programs for Diabetes Mellitus (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
      September 11, 2015 - Guidance for Industry: Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment … and Prevention. 2008. www.fda.gov/ downloads/ Drugs/Guidances/ucm071624.pdf.

1816. Healthcare Industry Waste and Lifecycle Assessment | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/lifecycle-assessment
      September 01, 2023 - antibiotics, hormone, non-steroidal anti-inflammatory, beta blockers, lipid regulators, and anti-depressant drugs … the most prevalent pharmaceuticals found in the environment. 12 , 16 There have been negative impacts

1817. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
      October 10, 2019 - Anticancer Drugs. 2016 Jan;27(1):1-8. doi: 10.1097/cad.0000000000000295. PMID: 26426520. 48.

1818. Disposition of Comments for CER 181 Mental Health Care (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
      December 19, 2016 - criteria used seem more appropriate for highly controlled clinical trials used to test the efficacy of drugs

1819. Disposition of Comments for CER 183 Tonsillectomy for OSDB (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
      January 17, 2017 - Drug Administration warnings about use of opioids such as codeine in children (http://www.fda.gov/Drugs

1820. Radiation Therapy for Brain Metastases: A Systematic Review | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/radiation-brain-metastases/protocol
      June 01, 2021 - Anticancer Drugs. 2016 Jan;27(1):1-8. doi: 10.1097/cad.0000000000000295. PMID: 26426520.